At Hovione we are constantly innovating to find better and more efficient ways of doing things.
Visit Hovione’s booth at the 12th Global Drug Delivery and Formulation Summit (DDF) and meet our team of experts.
Learn more about ASD-HIPROS – the most advanced and accurate screening platform able to identify the most efficient and stable Amorphous Solid Dispersion formulations by Spray Drying. Requiring as little as 5g of API and in just 6 weeks, this platform maximizes your chances of identifying a successful formulation, accelerating development towards commercial manufacturing and patient availability.
Featured Speakers: Mafalda Paiva - Group Leader, R&D Analytical Development and João Henriques - Group Leader, R&D Drug Product Development
Title: Performance Enhancement Strategies for Low Solubility APIs – do more with less
Session Track: Technology & Innovation
Date: Wednesday, March 17, 2021
Time: 09:25AM – 10:00AM GMT
Abstract: The presentation will address the main challenges in the formulation of ASDs, highlighting the importance of integrated development and the synergies between pre-formulation and commercial manufacturing expertise. Mafalda and João will also be presenting ASD HIPROS, our new state-of-the-art, science-based development platform for ASDs.
Conference Website: https://www.ddfevent.com/
Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.